United States
Software Service
Greece
GreeceEnterprise carbon managementCSRD / ISSB reporting platforms
532View Profile
Convexia
United StatesSoftware Service
- Founded
- 2025
- Team Size
- 1-10
- Annual Revenue
- Pre Revenue
- Number of Customers
- 5
- Stage
- Startup (< 3 years)
Convexia Overview
About Convexia
Convexia is a biotech and AI company building autonomous agents to source, evaluate, and accelerate overlooked drug assets. Its platform combines asset discovery, in silico scientific evaluation, market analysis, and expert human review to help biotech, pharma, and investment teams assess drug opportunities faster.
Company stageStartup (< 3 years)
Number of Customers5
Number of customers< 50
ClienteleGlobal
Geographic FocusNorth America
Typical EngagementAbove $100k
Founded2025
Reviews
No client reviews yet
If you have worked with Convexia, you can be the first to write one. Reviews are checked before they go live.
Contact
Talk to Convexia
AI-native platform accelerating drug discovery, clinical planning, and pharmaceutical commercialization
Details
convexia.bio
Head officeUnited States
More providers in ESG data, ratings & investing
View all
United States
ESG/sustainability report automation & AIESG data aggregation & analytics
1.3KView Profile
Netherlands
ESG data aggregation & analytics
2.4KView Profile
Reach your target audience with One Stop ESG
Fostering Sustainability, Building Connections: Through our platform, connecting with customers for your services and products is seamless and efficient.
View Pricing